-
Je něco špatně v tomto záznamu ?
Prolonged treatment planning can increase real rectal dose in 3D brachytherapy for cervical cancer
Z. Vlachová, M. Dolezel, K. Svozilova, P. Jaskova, D. Vitaskova, M. Matzenauer, J. Stuk, I. Hartmann,
Jazyk angličtina Země Polsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01 do 2022-01-31
Open Access Digital Library
od 2009-01-01
Health & Medicine (ProQuest)
od 2009-01-01 do 2022-01-31
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
32395135
DOI
10.5114/jcb.2020.94580
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Purpose: The purpose of this study was to evaluate the influence of 3D brachytherapy planning time on the real dose distribution. Material and methods: 10 patients with cervical cancer were evaluated using 2 computed tomography (CT) scans brachytherapy. The first scan was performed after the insertion of UVAG applicators, and the second was done after creating the treatment plan, just before the irradiation of first and third fraction. Both plans were compared in terms of changes of volumes and differences in the dose for high-risk organs using GEC-ESTRO Working Group parameters. Results: The median planning time was 54 minutes (36-64 minutes). The absolute median change of volume for bladder, rectum, and sigmoid was 32.1 cm3 (1.6-108.6 cm3), 5.6 cm3 (0.4-61.8 cm3), and 8.4 cm3 (0.2-74.1 cm3), respectively. This difference led to an increased dose for bladder and sigmoid for D0.1cc by 46.7 cGy and 25.7 cGy, for D1cc by 59.2 cGy and 11.8 cGy, and for D2cc by 44.7 cGy and 10 cGy, respectively, per each fraction. Measured volume change in case of rectum led to a decreased dose per each fraction for D0.1cc with 7.1 cGy, for D1cc with 3.5 cGy, and for D2cc with 4.8 cGy. We observed that statistically significant dependency between the planning time and the dose was proved for rectum. The longer time for planning, the higher dose for rectum. The correlation coefficient for D0.1cc was 0.6715 (p = 0.0061), for D1cc was 0.6404 (p = 0.011), and for D2cc was 0.5891 (p = 0.0197). Conclusions: Extended treatment planning time for brachytherapy due to the changes in topography of small pelvis can lead to different dose in high-risk organs than previously planned. It seems that the most significant changes are related to rectum.
Comprehensive Cancer Centre Multiscan Pardubice Czech Republic
Comprehensive Cancer Centre Novy Jicin Czech Republic
Faculty of Medicine Palacký University Olomouc Olomouc Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20019393
- 003
- CZ-PrNML
- 005
- 20210204123418.0
- 007
- ta
- 008
- 201103s2020 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5114/jcb.2020.94580 $2 doi
- 035 __
- $a (PubMed)32395135
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Vlachová, Zuzana $u Department of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic. Faculty of Medicine, Palacký University Olomouc, Olomouc, Czech Republic.
- 245 10
- $a Prolonged treatment planning can increase real rectal dose in 3D brachytherapy for cervical cancer / $c Z. Vlachová, M. Dolezel, K. Svozilova, P. Jaskova, D. Vitaskova, M. Matzenauer, J. Stuk, I. Hartmann,
- 520 9_
- $a Purpose: The purpose of this study was to evaluate the influence of 3D brachytherapy planning time on the real dose distribution. Material and methods: 10 patients with cervical cancer were evaluated using 2 computed tomography (CT) scans brachytherapy. The first scan was performed after the insertion of UVAG applicators, and the second was done after creating the treatment plan, just before the irradiation of first and third fraction. Both plans were compared in terms of changes of volumes and differences in the dose for high-risk organs using GEC-ESTRO Working Group parameters. Results: The median planning time was 54 minutes (36-64 minutes). The absolute median change of volume for bladder, rectum, and sigmoid was 32.1 cm3 (1.6-108.6 cm3), 5.6 cm3 (0.4-61.8 cm3), and 8.4 cm3 (0.2-74.1 cm3), respectively. This difference led to an increased dose for bladder and sigmoid for D0.1cc by 46.7 cGy and 25.7 cGy, for D1cc by 59.2 cGy and 11.8 cGy, and for D2cc by 44.7 cGy and 10 cGy, respectively, per each fraction. Measured volume change in case of rectum led to a decreased dose per each fraction for D0.1cc with 7.1 cGy, for D1cc with 3.5 cGy, and for D2cc with 4.8 cGy. We observed that statistically significant dependency between the planning time and the dose was proved for rectum. The longer time for planning, the higher dose for rectum. The correlation coefficient for D0.1cc was 0.6715 (p = 0.0061), for D1cc was 0.6404 (p = 0.011), and for D2cc was 0.5891 (p = 0.0197). Conclusions: Extended treatment planning time for brachytherapy due to the changes in topography of small pelvis can lead to different dose in high-risk organs than previously planned. It seems that the most significant changes are related to rectum.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dolezel, Martin $u Department of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic. Faculty of Medicine, Palacký University Olomouc, Olomouc, Czech Republic. First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Svozilova, Katerina $u Department of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Jaskova, Paulina $u Department of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Vitaskova, Denisa $u Department of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Matzenauer, Marcel $u Comprehensive Cancer Centre, Novy Jicin, Czech Republic.
- 700 1_
- $a Stuk, Jan $u Comprehensive Cancer Centre Multiscan, Pardubice, Czech Republic.
- 700 1_
- $a Hartmann, Igor $u Faculty of Medicine, Palacký University Olomouc, Olomouc, Czech Republic.
- 773 0_
- $w MED00205343 $t Journal of contemporary brachytherapy $x 1689-832X $g Roč. 12, č. 2 (2020), s. 118-123
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32395135 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201103 $b ABA008
- 991 __
- $a 20210204123415 $b ABA008
- 999 __
- $a ind $b bmc $g 1586170 $s 1109591
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 12 $c 2 $d 118-123 $e 20200430 $i 1689-832X $m Journal of contemporary brachytherapy $n J Contemp Brachytherapy $x MED00205343
- LZP __
- $a Pubmed-20201103